ROIV logo

Roivant Sciences (ROIV)

Profile

Full Name

Roivant Sciences Ltd.

Ticker Symbol

ROIV

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United Kingdom

IPO

December 8, 2020

Indexes

Not included

Website

http://roivant.com

Employees

908

Key Details

Price

$10.19(+3.35%)

Market cap

$7.27B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$124.80M(+103.65% YoY)

Annual EPS

$5.23(+468.31% YoY)

PE ratio

-

Next earnings date

May 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$10.19
ROIV price is $10.19

30-Day Relative Volume

0.92
ROIV 30-day relative volume is 0.92

Price Performance

Price Most recent change

+3.35%
ROIV price was up +3.35% on Apr 14, 2025

Price YTD change

-13.86%
ROIV price is down -13.86% since January 1st

Price 1-year change

-6%
ROIV price is down -6% year-on-year

Price 3-year change

+151.92%
ROIV price is up +151.92% over the past 3 years

Price Range

Price All-time high

$16.76
ROIV price is currently -39.20% below its historical high of $16.76

Price 3-year low

$2.52
ROIV price is currently +304.37% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$7.27B
ROIV market capitalization is $7.27 billion

Market cap 3-year change

+158.65%
ROIV market capitalization is up +158.65% over the past 3 years

Market cap All-time high

$10.14B
ROIV market capitalization is currently -28.28% below its historical high of $10.14 billion

Market cap sector rank

91.28%
ROIV market capitalization is higher than 91.28% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-11.54%
ROIV shares outstanding is down -11.54% year-on-year

Shares Outstanding 3-Year Change

+2.67%
ROIV shares outstanding is up +2.67% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.89
ROIV beta is 0.89

200-day SMA

$11.26
ROIV price is currently -9.53% below its 200-day simple moving average

50-day SMA

$10.44
ROIV price is currently -2.43% below its 50-day simple moving average

RSI

50.44
ROIV 14-day relative strength index is 50.44

Volume

0.92
ROIV 30-day relative volume is 0.92

ATR

$0.47
ROIV average true range is $0.47

10-day Historical Volatility

65.05%
ROIV 10-day historical volatility is 65.05%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$124.80M
ROIV annual revenue is $124.80 million

Revenue Analysts estimate

$141.31M
ROIV annual revenue is currently -11.69% lower than the consensus analysts' forecast

Revenue 1-year change

+103.65%
ROIV annual revenue is up +103.65% year-on-year

Revenue Sector rank

58.23%
ROIV annual revenue is higher than 58.23% of companies in Healthcare sector

EPS

EPS

$5.23
ROIV annual earnings per share is $5.23

EPS Analysts estimate

-$0.57
ROIV annual earnings per share is currently -1017.54% lower than the consensus analysts' forecast

EPS 1-year change

+468.31%
ROIV annual earnings per share is up +468.31% year-on-year

EPS Sector rank

95.86%
ROIV annual earnings per share is higher than 95.86% of companies in Healthcare sector

Profit

Gross profit

$109.23M
ROIV annual gross profit is $109.23 million

Gross margin

87.53%
ROIV annual gross profit margin is 87.53%

Operating profit

-$1.08B
ROIV annual operating income is -$1.08 billion

Operating margin

-865.37%
ROIV annual operating profit margin is -865.37%

Net income

$4.35B
ROIV annual net profit is $4.35 billion

Net margin

-
ROIV annual net profit margin value is unknown

Expenses

Total expenses

$1.20B
ROIV annual total expenses is $1.20 billion

Operating expenses

$1.19B
ROIV annual total operating expenses is $1.19 billion

Cost of goods sold

$15.56M
ROIV annual cost of goods sold is $15.56 million

Selling, general & administrative expenses

$687.44M
ROIV annual SGA is $687.44 million

Depreciation and amortization

$22.04M
ROIV annual depreciation & amortization is $22.04 million

Interest expense

$34.78M
ROIV annual interest expense is $34.78 million

Income tax

$22.22M
ROIV annual income tax is $22.22 million

EBIT & EBITDA

EBIT

$4.29B
ROIV annual earnings before interest & taxes is $4.29 billion

EBITDA

$4.31B
ROIV annual EBITDA is $4.31 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$7.22B
ROIV annual total assets is $7.22 billion

Non current assets

$490.65M
ROIV annual long term assets is $490.65 million

Current assets

$6.73B
ROIV annual total current assets is $6.73 billion

Cash and cash equivalents

$6.54B
ROIV annual cash & cash equivalents is $6.54 billion

Accounts receivable

$53.55M
ROIV annual accounts receivable is $53.55 million

Inventory

$35.25M
ROIV annual inventory is $35.25 million

Liabilities

Total liabilities

$773.95M
ROIV annual total liabilities is $773.95 million

Long term liabilities

$507.19M
ROIV annual total long term liabilities is $507.19 million

Current liabilities

$266.76M
ROIV annual total current liabilities is $266.76 million

Accounts payable

$53.23M
ROIV annual accounts payable is $53.23 million

Debt

Total debt

$499.75M
ROIV annual total debt is $499.75 million

Total debt 1-year change

+3.81%
ROIV annual total debt is up +3.81% year-on-year

Long term debt

$477.86M
ROIV annual long term debt is $477.86 million

Short term debt

$21.89M
ROIV annual short term debt is $21.89 million

Equity & Capital

Shareholders equity

$5.97B
ROIV annual stockholders equity is $5.97 billion

Book value

$5.97B
ROIV annual book value is $5.97 billion

Retained earnings

$576.17M
ROIV annual retained earnings is $576.17 million

Working capital

$6.47B
ROIV annual working capital is $6.47 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$765.27M
ROIV annual cash flow from operations is -$765.27 million

Cash from operations 1-year change

+9.26%
ROIV annual cash flow from operations is up +9.26% year-on-year

Cash from investing

$5.20B
ROIV annual cash flow from investing activities is $5.20 billion

Cash from investing 1-year change

+11854.55%
ROIV annual cash flow from investing activities is up +11854.55% year-on-year

Cash from financing

$419.36M
ROIV annual cash flow from financing activities is $419.36 million

Cash from financing 1-year change

-16.04%
ROIV annual cash flow from financing activities is down -16.04% year-on-year

CAPEX

CAPEX

$1.38M
ROIV annual capital expenditures is $1.38 million

CAPEX 1-year change

-89.11%
ROIV annual capital expenditures is down -89.11% year-on-year

Free Cash Flow

Free cash flow

-$766.65M
ROIV annual free cash flow is -$766.65 million

Free cash flow 1-year change

+10.45%
ROIV annual free cash flow is up +10.45% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

87.53%
ROIV annual gross profit margin is 87.53%

Operating margin

-865.37%
ROIV annual operating profit margin is -865.37%

Net margin

-
ROIV annual net profit margin value is unknown

ROA & ROE

ROA

90.49%
ROIV annual return on assets is 90.49%

ROE

107.97%
ROIV annual return on equity is 107.97%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ROIV price to earnings ratio value is unknown

PE ratio Sector rank

-
ROIV price to earnings ratio is unknown

PB Ratio

PB ratio

1.40
ROIV price to book ratio is 1.40

PB ratio Sector rank

52.59%
ROIV price to book ratio is higher than 52.59% of companies in Healthcare sector

PS Ratio

PS ratio

42.84
ROIV price to sales ratio is 42.84

PS ratio Sector rank

91.54%
ROIV price to sales ratio is higher than 91.54% of companies in Healthcare sector

Enterprise value

Enterprise value

$5.38B
ROIV enterprise value is $5.38 billion

Enterprise value Sector rank

88.51%
ROIV enterprise value is higher than 88.51% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

1.23
ROIV EV/EBITDA is 1.23

EV/EBITDA Sector rank

75.13%
ROIV EV/EBITDA is higher than 75.13% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

25.24
ROIV annual current ratio is 25.24

Quick ratio

25.10
ROIV annual quick ratio is 25.10

Leverage

Debt to equity

0.07
ROIV annual debt to equity ratio is 0.07

Interest coverage ratio

123.30
ROIV annual interest coverage ratio is 123.30

Risk & Stability

Piotroski F-Score

4
ROIV piotroski f-score is 4

Altman Z-Score

8.80
ROIV altman z-score is 8.80

Analyst ratings

Recent major analysts updates

Feb 11, 25 HC Wainwright & Co.
Buy
Nov 13, 24 HC Wainwright & Co.
Buy
Sep 19, 24 HC Wainwright & Co.
Buy
Sep 19, 24 Cantor Fitzgerald
Overweight
Sep 11, 24 HC Wainwright & Co.
Buy
Sep 11, 24 B of A Securities
Neutral
Sep 9, 24 Cantor Fitzgerald
Overweight
Aug 19, 24 HC Wainwright & Co.
Buy
Jul 10, 24 Piper Sandler
Overweight
Jun 18, 24 Cantor Fitzgerald
Overweight

Institutional Ownership

Similar stocks

HQY logo
HealthEquity (HQY)
RGEN logo
Repligen (RGEN)
MDGL logo
Madrigal Pharmaceuticals (MDGL)
TEM logo
Tempus AI (TEM)
CORT logo
Corcept Therapeutics Incorporated (CORT)
ENSG logo
Ensign (ENSG)
LNTH logo
Lantheus Holdings (LNTH)
BIO logo
Bio-Rad Laboratories (BIO)
HALO logo
Halozyme Therapeutics (HALO)
  • What is the ticker symbol for Roivant Sciences?
  • Does Roivant Sciences pay dividends?
  • What sector is Roivant Sciences in?
  • What industry is Roivant Sciences in?
  • What country is Roivant Sciences based in?
  • When did Roivant Sciences go public?
  • Is Roivant Sciences in the S&P 500?
  • Is Roivant Sciences in the NASDAQ 100?
  • Is Roivant Sciences in the Dow Jones?
  • When was Roivant Sciences's last earnings report?
  • When does Roivant Sciences report earnings?
  • Should I buy Roivant Sciences stock now?

What is the ticker symbol for Roivant Sciences?

The ticker symbol for Roivant Sciences is NASDAQ:ROIV

Does Roivant Sciences pay dividends?

No, Roivant Sciences does not pay dividends

What sector is Roivant Sciences in?

Roivant Sciences is in the Healthcare sector

What industry is Roivant Sciences in?

Roivant Sciences is in the Biotechnology industry

What country is Roivant Sciences based in?

Roivant Sciences is headquartered in United Kingdom

When did Roivant Sciences go public?

Roivant Sciences's initial public offering (IPO) was on December 8, 2020

Is Roivant Sciences in the S&P 500?

No, Roivant Sciences is not included in the S&P 500 index

Is Roivant Sciences in the NASDAQ 100?

No, Roivant Sciences is not included in the NASDAQ 100 index

Is Roivant Sciences in the Dow Jones?

No, Roivant Sciences is not included in the Dow Jones index

When was Roivant Sciences's last earnings report?

Roivant Sciences's most recent earnings report was on Feb 10, 2025

When does Roivant Sciences report earnings?

The next expected earnings date for Roivant Sciences is May 30, 2025

Should I buy Roivant Sciences stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page